The George Washington University Medical Faculty Associates (Site 1025) — Washington D.C., District of Columbia

The George Washington University Medical Faculty Associates (Site 1025) is a clinical research site located in Washington D.C., District of Columbia, United States 20037.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

The George Washington University Medical Faculty Associates (Site 1025) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The George Washington University Medical Faculty Associates (Site 1025)?

The George Washington University Medical Faculty Associates (Site 1025) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The George Washington University Medical Faculty Associates (Site 1025) conducted?

The George Washington University Medical Faculty Associates (Site 1025) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is The George Washington University Medical Faculty Associates (Site 1025) accredited by Crixeo Health?

The George Washington University Medical Faculty Associates (Site 1025) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The George Washington University Medical Faculty Associates (Site 1025)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.